Patricia Johansson Selected Research

Drug Therapy (Chemotherapy)

1/2020

Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Johansson Research Topics

Disease

4	Lymphoma (Lymphomas) 12/2023 - 12/2022
4	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2020
3	Neoplasms (Cancer) 01/2023 - 01/2020
2	Large Granular Lymphocytic Leukemia 01/2023 - 11/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023
1	Paraproteinemias (Monoclonal Gammopathy) 12/2023
1	Residual Neoplasm 01/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 12/2022
1	Leukemia 11/2022
1	T-Cell Leukemia (Leukemia, T Cell) 11/2022
1	Multiple Myeloma 04/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Cryoglobulinemia 01/2018
1	Wounds and Injuries (Trauma) 01/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013
1	Disease Progression 01/2013
1	Carcinogenesis 01/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2013
2	Immunoglobulin M (IgM)IBA 12/2023 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2022
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022 - 01/2020
1	venetoclaxIBA 04/2022
1	Kv1.3 Potassium ChannelIBA 04/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Alemtuzumab (Campath)FDA Link 12/2020
1	GranulinsIBA 01/2013
1	ProgranulinsIBA 01/2013

Therapy/Procedure

3	Radiotherapy 11/2023 - 12/2022
1	Aftercare (After-Treatment) 01/2023
1	Therapeutics 04/2022
1	Hematopoietic Stem Cell Transplantation 12/2020
1	Drug Therapy (Chemotherapy) 01/2020